GLP-1 and Metabolic Peptides
Vials and pens of retatrutide, tirzepatide, semaglutide and cagrilintide, with strengths from 2mg to 60mg.
Retatrutide
Tirzepatide
MOTS-c
SLU-PP-332
Semaglutide
AOD-9604
5-Amino-1MQ
Cagrilintide
Tesofensine
GLP-1 and Metabolic Peptides in more detail
Incretin receptor agonists
| Compound | Receptors | Code | Available strengths |
|---|---|---|---|
| Semaglutide | GLP-1 | , | 2mg, 5mg, 10mg |
| Tirzepatide | GIP, GLP-1 | LY3298176 | 5mg to 60mg |
| Retatrutide | GIP, GLP-1, glucagon | LY3437943 | 5mg to 40mg |
Cagrilintide stands apart: rather than acting at an incretin receptor, it is an amylin analogue. It is sold on its own, and it also comes already mixed into the blends.
Which other compounds share this shelf?
The rest of the shelf holds no incretin agonists. Small molecules: SLU-PP-332 and 5-Amino-1MQ. A growth hormone fragment: AOD-9604. Mitochondrial in origin: MOTS-c. A monoamine reuptake inhibitor: Tesofensine.
Which formats are available?
At 20mg, 30mg and 40mg, retatrutide and tirzepatide are each offered in two formats, vial or pen. A pen arrives as liquid, while a vial holds dry powder to be made up with bacteriostatic water.
Questions on Metabolic & GLP-1
Which compound here has the largest body of human data?
Semaglutide and tirzepatide, each having completed full clinical programmes under a licensed brand name. In its published record, retatrutide has got as far as phase 2.
In what way does a pen differ from a vial?
Only the state on arrival differs; compound and specification are identical. A vial is freeze-dried and needs making up, whereas a pen comes ready mixed.
Why is the per-milligram rate different for each size?
A large vial costs barely more to fill, label, pack and post than a small one, which brings the rate per milligram down. Every row shows that rate.